Owais, Asia
Chen, Hanna
Farooq, Hammad https://orcid.org/0000-0001-5691-298X
Thami, Prisca K.
McGurk, Kathryn A. https://orcid.org/0000-0002-5445-6906
Powell, George J.
DeSantiago, Jaime
Abbas, Talla
Sridhar, Arvind
Pavel, Arif
Webster, Gregory
Merrill, Bradley
Ware, James S. https://orcid.org/0000-0002-6110-5880
Ng, Fu Siong https://orcid.org/0000-0002-8681-4368
Darbar, Dawood
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NIH R01 HL148444)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NIH T32 HL139439)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL164773)
American Heart Association (24PRE1178922)
American Heart Association (25CDA1447820)
Sir Jules Thorn Charitable Trust (21JTA)
RCUK | Medical Research Council (MC_UP_1605/13)
British Heart Foundation (RG/19/6/34387)
British Heart Foundation (RE/18/4/34215)
British Heart Foundation (FS/IPBSRF/22/27059)
VA- Veterans Affairs
Article History
Received: 4 April 2025
Accepted: 2 May 2026
First Online: 19 May 2026
Competing interests
: Prof Ware has consulted for MyoKardia Inc, Pfizer, Foresite Labs, Health Lumen, and Tenaya Therapeutics and has received research support from Bristol Myers-Squibb. The remaining authors declare no competing interests.